YOLFTbeta
47

NatureWise Biotech & Medicals Corporation

4732 · TWO · Healthcare / Biotechnology

15.25TWD+0.05 (+0.33%)

Price History

Full chart

Market Stats

Previous Close15.20
Open14.85
Day Range14.85 – 15.25
52-Week Range15.25 – 24.60
Volume7.00K
Market Cap874.64M
P/E (TTM)0.00
Forward P/E0.00
EPS-2.74
Dividend Yield0.00%
Beta0.55
50-Day Avg17.17
200-Day Avg18.77

About

NatureWise Biotech & Medicals Corporation engages in the research and development of Western medicine, Chinese medicine, and biotechnology in Taiwan. It also sells food and beverages. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; and green propolis and red yeast rice products. The company was founded in 1990 and is headquartered in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOZhong Yang Huang
  • HeadquartersNo. 36, Bade Road, Taipei, Taiwan, Taiwan
  • Websitehttps://www.naturewise.com.tw

Leadership

  • Zhong Yang HuangChairman & President
  • Jun Kai ChenChief Financial Officer and Assistant Vice President
  • Yuling YangAccounting Supervisor
  • Xing Ling CaiMarketing Manager
  • Nian Ci HongTreasurer & Audit Office Manager

Financials

Income Statement

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue57.53M69.10M108.48M307.46M306.92M249.80M228.59M160.14M224.32M176.77M
Growth (%)-+20.11%+56.98%+183.43%-0.18%-18.61%-8.49%-29.94%+40.08%-21.20%
Cost of Revenue34.17M39.45M58.21M146.27M135.53M114.91M109.60M72.76M104.12M91.07M
Gross Profit23.36M29.65M50.27M161.20M171.38M134.90M118.99M87.38M120.20M85.70M
Gross Margin40.60%42.91%46.34%52.43%55.84%54.00%52.05%54.56%53.58%48.48%
Operating Expense89.64M89.60M72.05M128.31M113.46M107.92M92.64M83.94M132.24M192.56M
Operating Income-66.28M-59.95M-21.78M32.88M57.92M26.98M26.35M3.43M-12.04M-106.86M
Operating Margin-115.21%-86.76%-20.08%10.69%18.87%10.80%11.53%2.14%-5.37%-60.45%
EBITDA-63.61M-55.59M-8.02M44.44M69.97M38.27M37.29M20.39M7.46M-90.41M
EBITDA Margin-110.56%-80.45%-7.39%14.45%22.80%15.32%16.31%12.73%3.32%-51.15%
Net Income-60.01M-60.49M-14.81M39.70M65.32M30.81M30.02M10.12M897.00K-92.28M
Net Income Margin-104.31%-87.54%-13.66%12.91%21.28%12.33%13.13%6.32%0.40%-52.20%
R&D55.32M52.40M31.67M78.19M68.14M69.46M49.48M30.01M72.06M138.41M
R&D as % of Total Revenue96.16%75.83%29.20%25.43%22.20%27.80%21.65%18.74%32.13%78.30%
Interest Expense---60.00K58.00K32.00K40.00K52.00K99.00K70.00K
Interest Expense % of Total Revenue---0.02%0.02%0.01%0.02%0.03%0.04%0.04%

Balance Sheet

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets350.69M308.23M306.14M606.64M658.24M704.57M692.60M698.45M840.59M712.87M
Total Liabilities11.19M29.22M42.03M73.90M59.93M80.22M51.09M64.89M57.03M72.09M
Total Equity339.50M279.00M264.11M532.74M598.31M624.35M641.51M633.56M741.02M624.35M
Cash25.94M38.75M30.42M254.53M162.57M155.56M98.97M112.55M319.95M97.68M
Total Debt270.00K297.00K2.88M12.22M3.83M12.56M4.99M10.68M3.77M-
Net Debt-25.67M-38.45M-27.55M-242.31M-158.74M-143.00M-93.98M-101.87M-316.18M-

Cash Flow

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-60.57M-53.83M-20.60M40.96M55.57M33.72M13.85M62.20M-2.79M-111.74M
Investing Cash Flow-50.63M66.61M9.91M-48.32M-143.73M-32.05M-51.93M-19.72M66.94M-
Financing Cash Flow-1.38M27.00K2.58M232.62M-4.07M-8.56M-22.36M-28.66M142.83M-
Capital Expenditure4.42M483.00K1.68M2.88M2.73M176.00K152.00K634.00K143.00K1.38M
Free Cash Flow-64.99M-54.31M-22.27M38.08M77.37M28.89M17.33M61.57M-2.94M-113.12M
Dividends Paid-----4.65M14.79M24.64M9.86M-
FCF to OCF107.31%100.90%108.15%92.96%139.24%85.67%125.10%98.98%105.12%101.24%
Dividend Paid to FCF-----16.10%85.33%40.03%-335.50%-

Key Statistics & Ratios

Market Cap874.64M
Enterprise Value499.57M
Trailing P/E0.00
Forward P/E0.00
Price / Sales5.01
Price / Book1.57
EPS-2.74
Book Value11.50
Revenue (TTM)174.62M
Gross Profit (TTM)81.25M
EBITDA-163.76M
Profit Margin-76.55%
Operating Margin-106.36%
Return on Equity-26.83%
Return on Assets-14.84%
Shares Outstanding48.46M
Shares Float32.76M
Beta0.55
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.18Aug 27, 2024
20231×
0.44Aug 29, 2023
20221×
0.26Aug 19, 2022
20211×
0.09Sep 13, 2021

Stock Splits

  • Sep 13, 20211060:1000